Logo - springer
Slogan - springer

Biomedical Sciences - Pharmacology & Toxicology | Archives of Toxicology - incl. option to publish open access

We’re working on a new version of this journal site - preview it now
Archives of Toxicology

Archives of Toxicology

Editor-in-Chief: Jan G. Hengstler
Deputy Editor-in-Chief: Hermann M. Bolt

ISSN: 0340-5761 (print version)
ISSN: 1432-0738 (electronic version)

Journal no. 204

151,50 € Personal Rate e-only
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 12 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy

Read this Journal on Springerlink

For authors and editors

  • Journal Citation Reports®
    2018 Impact Factor
  • 5.741
  • Aims and Scope

    Aims and Scope


    The Archives of Toxicology aim to promote our understanding of toxic as well as pathophysiological mechanisms relevant to the mode of action of chemicals on human and mammalian cells and organisms. Particularly welcome are Short Communications, Review Articles, Original Articles, and Commentaries that focus on:

    • molecular mechanisms of toxic substances
    • in vitro techniques for toxicity testing and regulatory toxicology
    • advances in "omics" techniques for identification and classification of toxic substances
    • mechanisms and relevance of metabolic activation and inactivation

    Additional information

    Modern toxicology faces several major challenges. Firstly, the available toxicological data are insufficient for a large number of chemicals to which humans are exposed. Because our testing capacities are not sufficient to evaluate each individual compound or even mixtures of compounds in a reasonable time, new, more efficient techniques and testing strategies are required. Secondly, toxicology must keep pace with the rapidly growing knowledge about the molecular mechanisms responsible for adverse health effects because without this knowledge, toxicological risk evaluation will remain incomplete. Therefore, articles examining toxic as well as pathophysiological mechanisms relevant to the mode of action of chemicals on the human and mammalian organism will continue to be a major focus of our journal. Thirdly, advances in "omics" technologies and systems biology approaches have provided fresh insight into the complex interrelationships among the large numbers of factors involved. Therefore in future, a major challenge will be to model biological systems and quantitatively simulate perturbations by toxic substances. Finally, unrealistic expectations by parts of our society, including some politicians, represent a major challenge to toxicology. One particular example is the unrealistic expectation that animal experiments can be replaced by in vitro techniques within a few years, without increasing the risk of adverse consequences for human health. The opinion that virtually all toxicity testing can be conducted in human cell lines or primary cells and the required dose-response relationships can be achieved by pharmacokinetic models is an easy one to have. Unfortunately, being able to experimentally deliver such results is extremely challenging. Authors who have achieved specific progress in this important field of research are particularly encouraged to submit their results to our journal.
    A new feature of the journal is the forum "Letters to the Editor" which allows discussion of topics relevant to toxicology. Importantly, this forum is not limited to articles published in our journal but includes all publications and topics relevant to the field of toxicology. Naturally, the "Letter to the Editor" forum is independent of the editors' opinions and contributions are published as soon as technically possible (online publication within 3 weeks), to stimulate a lively debate on cutting-edge topics in toxicology.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors

    Instructions for Authors


  • Author Academy: Training for Authors
  • Copyright Information

    Copyright Information


    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.

    © Springer-Verlag Berlin Heidelberg

Services for the Journal

Alerts for this journal


Get the table of contents of every new issue published in Archives of Toxicology.